MX2012009523A - Tratamiento de afecciones alergicas dermatologicas. - Google Patents
Tratamiento de afecciones alergicas dermatologicas.Info
- Publication number
- MX2012009523A MX2012009523A MX2012009523A MX2012009523A MX2012009523A MX 2012009523 A MX2012009523 A MX 2012009523A MX 2012009523 A MX2012009523 A MX 2012009523A MX 2012009523 A MX2012009523 A MX 2012009523A MX 2012009523 A MX2012009523 A MX 2012009523A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- allergic conditions
- dermatological allergic
- dermatological
- methanone
- Prior art date
Links
- 206010027654 Allergic conditions Diseases 0.000 title abstract 2
- WCJRDLYNOVMUTE-UHFFFAOYSA-N [4-[5-(aminomethyl)-2-fluorophenyl]piperidin-1-yl]-[7-fluoro-1-(2-methoxyethyl)-4-(trifluoromethoxy)indol-3-yl]methanone Chemical compound C12=C(OC(F)(F)F)C=CC(F)=C2N(CCOC)C=C1C(=O)N(CC1)CCC1C1=CC(CN)=CC=C1F WCJRDLYNOVMUTE-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describe un tratamiento para una afección alérgica dermatológica, que usa un compuesto: como [4-(5-aminometil-2-fluor ofenil)piperidin-1-il][7-fluoro-1-(2-metoxietil)-4-trifluorometox i-1H-indol-3-iI]metanona.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30765010P | 2010-02-24 | 2010-02-24 | |
| FR1060021 | 2010-12-02 | ||
| PCT/US2011/025785 WO2011106334A1 (en) | 2010-02-24 | 2011-02-23 | Treatment of dermatological allergic conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012009523A true MX2012009523A (es) | 2012-08-31 |
Family
ID=43901272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012009523A MX2012009523A (es) | 2010-02-24 | 2011-02-23 | Tratamiento de afecciones alergicas dermatologicas. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120309790A1 (es) |
| EP (1) | EP2538942A1 (es) |
| JP (1) | JP2013520506A (es) |
| KR (1) | KR20130009769A (es) |
| CN (1) | CN102858336A (es) |
| AR (1) | AR080255A1 (es) |
| AU (1) | AU2011220909A1 (es) |
| BR (1) | BR112012020965A2 (es) |
| CA (1) | CA2790946A1 (es) |
| MX (1) | MX2012009523A (es) |
| RU (1) | RU2521357C2 (es) |
| SG (1) | SG183342A1 (es) |
| TW (1) | TW201141478A (es) |
| UY (1) | UY33242A (es) |
| WO (1) | WO2011106334A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002515891A (ja) * | 1997-12-19 | 2002-05-28 | スミスクライン・ビーチャム・コーポレイション | 新規なピペリジン含有化合物 |
| GB0012362D0 (en) * | 2000-05-22 | 2000-07-12 | Aventis Pharma Ltd | Chemical compounds |
| DOP2005000039A (es) * | 2004-03-26 | 2005-10-31 | Aventis Pharma Inc | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos |
| HRP20151338T1 (hr) * | 2008-08-22 | 2016-01-15 | Sanofi | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoksi-etil)-4trifluorometoksi-1h-indol-3-il]metanon kao inhibitor triptaze mastocita |
-
2011
- 2011-02-23 AR ARP110100550A patent/AR080255A1/es unknown
- 2011-02-23 TW TW100105893A patent/TW201141478A/zh unknown
- 2011-02-23 BR BR112012020965A patent/BR112012020965A2/pt not_active IP Right Cessation
- 2011-02-23 MX MX2012009523A patent/MX2012009523A/es not_active Application Discontinuation
- 2011-02-23 AU AU2011220909A patent/AU2011220909A1/en not_active Abandoned
- 2011-02-23 CN CN2011800206193A patent/CN102858336A/zh active Pending
- 2011-02-23 WO PCT/US2011/025785 patent/WO2011106334A1/en not_active Ceased
- 2011-02-23 JP JP2012555084A patent/JP2013520506A/ja not_active Abandoned
- 2011-02-23 CA CA2790946A patent/CA2790946A1/en not_active Abandoned
- 2011-02-23 KR KR1020127023697A patent/KR20130009769A/ko not_active Withdrawn
- 2011-02-23 SG SG2012060711A patent/SG183342A1/en unknown
- 2011-02-23 RU RU2012140438/15A patent/RU2521357C2/ru not_active IP Right Cessation
- 2011-02-23 EP EP11708360A patent/EP2538942A1/en not_active Withdrawn
- 2011-02-24 UY UY0001033242A patent/UY33242A/es not_active Application Discontinuation
-
2012
- 2012-08-20 US US13/589,525 patent/US20120309790A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013520506A (ja) | 2013-06-06 |
| TW201141478A (en) | 2011-12-01 |
| KR20130009769A (ko) | 2013-01-23 |
| EP2538942A1 (en) | 2013-01-02 |
| CA2790946A1 (en) | 2011-09-01 |
| BR112012020965A2 (pt) | 2016-05-03 |
| CN102858336A (zh) | 2013-01-02 |
| US20120309790A1 (en) | 2012-12-06 |
| WO2011106334A1 (en) | 2011-09-01 |
| UY33242A (es) | 2011-09-30 |
| AU2011220909A1 (en) | 2012-09-13 |
| SG183342A1 (en) | 2012-09-27 |
| RU2012140438A (ru) | 2014-03-27 |
| RU2521357C2 (ru) | 2014-06-27 |
| AR080255A1 (es) | 2012-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012045089A3 (en) | Methods for the treatment of allergic diseases | |
| NZ597517A (en) | 5-fluoropyrimidinone derivatives | |
| TN2012000578A1 (en) | Tetrahydro-pyrido-pyrimidine derivatives | |
| PH12012502128B1 (en) | Chemical compounds | |
| WO2011080568A8 (en) | Novel pyrimidine compounds as mtor and pi3k inhibitors | |
| WO2011153157A3 (en) | Benzoquinolone inhibitors of vmat2 | |
| IN2012DN02081A (es) | ||
| IN2012DN00692A (es) | ||
| MX2012001690A (es) | Heterociclos microbicidas. | |
| MX2013012652A (es) | Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparacion y su uso como antagonistas p2y12. | |
| WO2012013282A8 (en) | Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k | |
| NZ597483A (en) | N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives | |
| MX2013005751A (es) | Quinazolincarboxamida azetidinas. | |
| MX2012001623A (es) | Derivados de 5-fluoro-2-oxopirimidina-1 (2h)-carboxilato. | |
| NZ597570A (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
| CA2887539C (en) | Azaquinazoline carboxamide derivatives | |
| WO2012074869A8 (en) | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture | |
| GEP20156244B (en) | New tertiary 8-hydroxyquinoline-7- carboxamide derivatives and usage thereof | |
| IL225755A0 (en) | Amido-6 derivatives of epoxymorphinans-a5, 4 for the treatment of pain | |
| UA108126C2 (uk) | Спосіб отримання співполімеру натрійкарбоксиметилцелюлози й госиполу | |
| MX2013005825A (es) | Benzoxazepinas como inhibidores de objetivo de rapamicina en mamiferos (mtor) y metodos de uso y fabricacion. | |
| MX2012009523A (es) | Tratamiento de afecciones alergicas dermatologicas. | |
| TN2012000381A1 (en) | 2-aldoximino-5-fluoropyrimidine derivatives | |
| MX2012006741A (es) | Tratamiento para la enfermedad inflamatoria del intestino. | |
| HK1184968A (en) | Methods of use of cyclic amide derivatives to treat schizophrenia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |